Stockreport

Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences

Praxis Precision Medicines, Inc.  (PRAX) 
PDF BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into [Read more]